. 2019 Jul 10;10(18):4208–4216. doi: 10.7150/jca.33457

Table 2.

Univariate and multivariate analyses of the overall survival of lung adenocarcinoma patients

Clinicopathological features		Univariate analyses			Multivariate analyses
Clinicopathological features		HR	95% (CI)	P value	HR	95% (CI)	P value
Age (years)	≤40	1.000	0.919-1.710	0.547
Age (years)	>40	1.253	0.919-1.710	0.547
Gender	Female	1.000	0.825-1.536	0.457
Gender	Male	1.125	0.825-1.536	0.457
TNM stage	Stage I - II	1.000	1.577-3.076	<0.001**	1.000	1.546-3.021	<0.001**
TNM stage	Stage III - IV	3.591	1.577-3.076	<0.001**	2.161	1.546-3.021	<0.001**
Histological type	Mixed Subtype	1.000	0.700-1.585	0.262
Histological type	Other Subtype	1.053	0.700-1.585	0.262
Tumour size	≤3 cm	1.000	1.692-3.181	0.017*	1.000	1.246-1.729	0.175
Tumour size	>3 cm	2.458	1.692-3.181	0.017*	1.685	1.246-1.729	0.175
DDX11 expression	Low	1.000	1.783-2.983	0.024*	1.000	1.536-2.966	0.036*
DDX11 expression	High	2.334	1.783-2.983	0.024*	2.021	1.536-2.966	0.036*

Notes: *P<0.05. **P<0.01.

Abbreviations: TNM: tumour-node-metastasis; HR: hazard ratio; CI: confidential interval; DDX11: DEAD/H-box helicase 11.